Wilmington Savings Fund Society’s VanEck Biotech ETF BBH Stock Holding History

Wilmington Savings Fund Society’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$163K	Hold	800	–	–	﹤0.01%	636
2026 Q1	$150K	Hold	800	–	–	﹤0.01%	655
2025 Q4	$151K	Hold	800	–	–	﹤0.01%	656
2025 Q3	$133K	Sell	800 -232	-22%	-$37.8K	﹤0.01%	677
2025 Q2	$158K	Buy	1,032 +18	+2%	+$2.68K	﹤0.01%	883
2025 Q1	$160K	Buy	1,014 +30	+3%	+$4.87K	﹤0.01%	862
2024 Q4	$154K	Buy	984 +46	+5%	+$7.74K	﹤0.01%	913
2024 Q3	$166K	Buy	+938	New	+$166K	﹤0.01%	873

Other funds holding BBH

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

LJAC

L.J. Altfest & Co New York $1.03B AUM 36.74% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

BFC

Blue Fin Capital Warren, Rhode Island $692M AUM 27.29% 1-Year Est. Return

Wilmington Savings Fund Society's BBH Position: Q2 2026 in Review

Wilmington Savings Fund Society held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 800 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Wilmington Savings Fund Society first reported a position in BBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $166K in Q3 2024. 40 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Wilmington Savings Fund Society held 800 shares of VanEck Biotech ETF worth $163K as of Q2 2026.
Wilmington Savings Fund Society left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #636 holding.
Wilmington Savings Fund Society first reported a position in VanEck Biotech ETF in Q3 2024 and has held it in 8 quarters since.
Wilmington Savings Fund Society's VanEck Biotech ETF position peaked at $166K in Q3 2024.
40 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.